s interest grows in toughening the Sunshine Act in the U.S., a new analysis finds requirements for reporting financial relationships between drug makers and doctors in nine European countries are inconsistent and often inadequate, and the data is also sometimes hard to access.

For instance, only three countries — France, Portugal, and Latvia — have laws requiring companies to report financial ties. Five others follow a self-policing system established by an industry trade group, which means these countries allow physicians to choose whether disclosure reports are filed. And countries that adhere to the industry approach exclude food and drinks from being reported.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.